Thursday, March 09, 2017 12:00:52 PM
Hartman partnered with Laborde with favorable terms to bring to market a CBD pain patch (and other products) that could quickly generate revenue. This revenue generation would then allow for BIEI to become self sustaining so they could obtain traditional, non dilutive financing. This would also help them negotiate with potential partners for their cancer research.
IMO this has all been executed well and Hartman will continue to push this company forward.
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM